Neuromuscular monitoring: tof and ptc

8 min read Last updated April 8, 2026

Clinical use: how to apply TOF and PTC in theatre/ICU

  • Choose the right modality for the depth of block
    • If TOF count 1–4 present: use TOF count and TOF ratio (quantitative preferred).
    • If TOF count = 0: use PTC to quantify deep block and guide timing of reversal/return of TOF.
  • Suggested workflow (practical)
    • Before NMBA: apply electrodes, ensure supramaximal current, obtain baseline response (control).
    • Induction/intubation: TOF can confirm onset (loss of twitch) but clinical conditions depend on muscle group monitored.
    • Maintenance: titrate NMBA to surgical requirement; avoid “blind top-ups”.
    • Emergence: aim for quantitative TOF ratio ≥ 0.9 before extubation (≥0.95 often advised for best airway safety).
  • Reversal strategy linked to monitoring
    • Neostigmine: only when some spontaneous recovery present (e.g. TOF count ≥ 2); ceiling effect—ineffective in profound block.
    • Sugammadex: dose by depth (moderate vs deep); can reverse deep block (PTC present) rapidly.
    • If no PTC: indicates very profound block—expect longer time to recovery; reversal may be delayed/ineffective depending on agent and context.
  • Site selection affects interpretation
    • Ulnar nerve/adductor pollicis: best for recovery and extubation decisions (more sensitive to NMBA).
    • Facial nerve/orbicularis oculi or corrugator supercilii: better reflects laryngeal/diaphragmatic onset; less reliable for recovery endpoints.

Core concepts: what TOF and PTC measure

  • Neuromuscular monitoring uses peripheral nerve stimulation to infer neuromuscular transmission at the NMJ.
  • Train-of-four (TOF): 4 supramaximal stimuli at 2 Hz (over 2 seconds).
    • TOF count: number of visible/measured twitches (0–4).
    • TOF ratio (T4/T1): degree of fade; requires quantitative measurement for accuracy.
  • Post-tetanic count (PTC): used when TOF count is 0 to assess deep block.
    • Technique: tetanus 50 Hz for 5 s, pause ~3 s, then single twitches at 1 Hz; count responses.
    • Physiology: tetanus causes post-tetanic facilitation (increased ACh mobilisation) allowing transient responses despite deep block.

Physiology and pharmacology underpinning fade

  • Non-depolarising NMBAs: produce fade (TOF, tetanus) due to presynaptic inhibition of ACh mobilisation plus postsynaptic receptor block.
  • Depolarising block (suxamethonium): Phase I typically no fade; Phase II resembles non-depolarising with fade.
  • Post-tetanic facilitation can transiently increase twitch responses; therefore avoid repeated tetani too frequently (can distort subsequent measurements).

Stimulation technique and equipment set-up

  • Stimulus must be supramaximal to ensure consistent nerve activation (commonly 30–60 mA; higher may be needed with oedema/poor contact).
  • Electrode placement: over the nerve (negative electrode distal) with good skin contact; avoid placement over muscle belly.
  • Minimise artefact: immobilise the limb, avoid surgical manipulation, maintain temperature (hypothermia reduces twitch).
  • Allow adequate intervals between assessments
    • TOF: commonly every 10–20 s if needed; in routine practice less frequent.
    • PTC: wait at least several minutes (often ~3–6 min) before repeating to avoid facilitation confounding.

Qualitative vs quantitative monitoring

  • Qualitative (subjective): visual or tactile assessment of fade; cannot reliably detect TOF ratio between ~0.4 and 0.9.
  • Quantitative (objective): provides TOF ratio; recommended to confirm recovery (≥0.9).
    • Acceleromyography (AMG): measures acceleration of thumb; needs preload and calibration; may over-read at recovery (TOF ratio >1.0) so normalise to baseline.
    • Electromyography (EMG): measures compound muscle action potential; less dependent on movement; useful when thumb movement restricted.
    • Mechanomyography (MMG): gold standard in research (force transducer), rarely used clinically.

Interpretation: TOF count, TOF ratio, and PTC

  • TOF count reflects depth of block but is not equivalent to TOF ratio (recovery of count precedes recovery of ratio).
  • TOF ratio thresholds
    • TOF ratio <0.9: residual paralysis risk (airway obstruction, aspiration, hypoventilation, impaired swallow).
    • TOF ratio ≥0.9: minimum accepted for extubation; many advocate ≥0.95 when feasible.
  • PTC interpretation (deep block)
    • Lower PTC = deeper block; PTC rising predicts return of TOF responses.
    • PTC of 1–2: very deep; TOF likely absent for some time.
    • PTC ~5–10: deep but recovering; TOF may return soon (timing depends on agent/dose/patient factors).

Clinical endpoints and muscle group differences

  • Different muscles recover at different rates: diaphragm/larynx recover earlier than adductor pollicis.
  • Implication: acceptable surgical relaxation (e.g. at diaphragm) may coexist with significant residual block at adductor pollicis; hence use adductor pollicis for extubation decisions.
  • Facial nerve monitoring can mislead at end of case (may suggest recovery earlier than at upper airway dilators).

Reversal agents: linking doses to monitoring (principles)

  • Neostigmine (with antimuscarinic): best for shallow/moderate block with spontaneous recovery; avoid giving at profound block (TOF 0) due to poor efficacy and risk of cholinergic effects without benefit.
  • Sugammadex (for aminosteroid NMBAs e.g. rocuronium/vecuronium): dosing depends on depth (e.g. moderate vs deep); can reverse deep block guided by PTC.
  • Always confirm recovery with quantitative TOF ratio rather than time since reversal.
Describe how you would set up and perform train-of-four monitoring at the ulnar nerve.

Cover electrode placement, stimulus settings, baseline calibration, and how you minimise artefact.

  • Position hand/arm to allow free thumb movement; consider a thumb preload if using acceleromyography.
  • Place electrodes over the ulnar nerve at the wrist (negative electrode distal); ensure good skin contact.
  • Set supramaximal current (often 30–60 mA) and confirm consistent twitch at baseline before NMBA.
  • Deliver TOF: 4 stimuli at 2 Hz; record TOF count and (if quantitative) TOF ratio.
  • Control confounders: temperature, limb movement, surgical manipulation, poor electrode contact, oedema.
Explain the physiological basis of fade in TOF with non-depolarising neuromuscular block.

Examiners want presynaptic + postsynaptic mechanisms and the link to repetitive stimulation.

  • Postsynaptic: competitive antagonism at nicotinic ACh receptors reduces endplate potential and twitch height.
  • Presynaptic: blockade of facilitatory nicotinic receptors reduces mobilisation/release of ACh during repetitive stimulation.
  • Result: progressive reduction in twitch responses (T4 < T1), quantified as TOF ratio (T4/T1).
A patient has TOF count 4 but obvious fade on tactile assessment. What does this mean and what are the limitations?

This is a classic FRCA theme: TOF count alone is insufficient; qualitative assessment is insensitive near recovery.

  • TOF count 4 can occur with significant residual block; TOF ratio may still be well below 0.9.
  • Tactile/visual assessment cannot reliably detect fade once TOF ratio is roughly >0.4; you may miss clinically important residual weakness.
  • Use quantitative monitoring to confirm TOF ratio ≥0.9 before extubation.
Describe the post-tetanic count (PTC) technique and what it is used for.

State the sequence, frequencies, and clinical purpose (deep block when TOF=0).

  • Indication: TOF count = 0; need to assess deep neuromuscular block and predict return of TOF.
  • Deliver tetanus: 50 Hz for 5 seconds.
  • Pause ~3 seconds, then deliver single twitches at 1 Hz and count the number of responses (PTC).
  • Mechanism: post-tetanic facilitation increases ACh availability transiently, allowing responses despite deep block.
How do you interpret PTC values clinically?

Avoid over-precise time predictions; focus on directionality and implications for reversal/return of TOF.

  • Lower PTC indicates deeper block; rising PTC indicates recovery and predicts earlier return of TOF responses.
  • PTC 1–2: very deep block; expect prolonged time before TOF returns (agent/dose dependent).
  • PTC around 5–10: deep but recovering; TOF responses may return relatively soon.
  • No PTC: extremely profound block; avoid repeated tetani and reassess later; consider pharmacology/context (hypothermia, organ failure).
Why should you avoid frequent repetition of tetanic stimulation/PTC?

This often appears as a short viva question on limitations of PTC.

  • Tetanic stimulation causes post-tetanic facilitation, which can temporarily increase subsequent twitch responses and confound interpretation.
  • It may lead you to underestimate the depth of block if repeated too soon.
  • Allow several minutes between PTC assessments (commonly ~3–6 min).
What TOF ratio is considered safe for extubation and why?

Link the number to clinical consequences of residual block.

  • Aim for quantitative TOF ratio ≥0.9 (many advocate ≥0.95) to minimise residual paralysis.
  • Residual block is associated with impaired upper airway dilator function, hypoventilation, aspiration risk, and postoperative pulmonary complications.
  • Qualitative monitoring is unreliable near this threshold; quantitative monitoring is preferred.
Compare monitoring at the adductor pollicis vs facial muscles. When would you choose each?

A common structured viva: onset vs recovery, and what each site represents.

  • Adductor pollicis (ulnar nerve): more sensitive to NMBAs; recovers later; best for assessing recovery and extubation readiness.
  • Facial nerve (corrugator/orbicularis): reflects onset at laryngeal/diaphragmatic muscles more closely; useful for intubation conditions and early block assessment.
  • Pitfall: facial monitoring may suggest adequate recovery earlier than adductor pollicis; don’t use it alone to decide extubation.
A patient has TOF count 0 at the end of surgery. What are your next steps?

Examiners want a safe, monitoring-led plan including PTC, reversal choice, and ventilation strategy.

  • Confirm correct set-up: supramaximal current, electrode contact, temperature, and that you are stimulating the intended nerve.
  • Perform PTC to quantify deep block and guide timing/dose of reversal (agent dependent).
  • If using neostigmine: defer until spontaneous recovery (e.g. TOF count ≥2) because of ceiling effect.
  • If aminosteroid NMBA used: consider sugammadex according to depth (including deep block guided by PTC).
  • Continue controlled ventilation and sedation as needed; recheck with quantitative monitoring until TOF ratio ≥0.9.
What are the main sources of error in neuromuscular monitoring and how do you mitigate them?

This maps well to an equipment/monitoring viva: list problems and practical fixes.

  • Non-supramaximal stimulation (underestimates block): increase current and confirm stable baseline twitch.
  • Poor electrode contact/placement: clean/dry skin, correct positioning over nerve, replace electrodes if needed.
  • Movement restriction (casts, tucked arms) affects AMG: use EMG if movement limited; ensure thumb free if AMG.
  • Temperature/hypoperfusion: warm the limb and patient; recognise hypothermia reduces twitch and delays recovery.
  • Calibration/normalisation issues (AMG): calibrate and normalise to baseline to avoid TOF ratio >1.0 misinterpretation.
How would you recognise and manage residual neuromuscular block in recovery?

Focus on clinical features, monitoring confirmation, and safe management.

  • Recognition: airway obstruction, hypoventilation, desaturation, weak cough, inability to sustain head lift/hand grip (clinical tests are insensitive).
  • Confirm with quantitative TOF ratio if available; reassess electrode placement/site.
  • Management: airway support, oxygen, ventilation as needed; administer appropriate reversal depending on agent and depth; continue monitoring until TOF ratio ≥0.9.

0 comments